IBO
IMPACT BIOMEDICAL INC.
Key Financials
Net Income
$-11838000
↑ 52.1%
Revenue
$32000
↓ 36.0%
EPS (Diluted)
$-0.38
↑ 83.5%
Operating Income
$-4282000
↑ 85.1%
Total Assets
$17.4M
↓ 14.2%
Shareholders' Equity
$12.6M
↑ 196.1%
Cash & Equivalents
$3000.00
↓ 99.8%
Total Liabilities
$1.9M
↓ 85.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IBO |
| Company Name | IMPACT BIOMEDICAL INC. |
| CIK | 1834105 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 585 232 1500 |